No Prescription |
 |
 | ||
|
Clomazol Femcare |
|
| ||
No Prescription » Prescription Drugs 4 » Clomazol Femcare Clomazol vaginal cream is used to treat a fungal infection in the vagina and vulval area (thrush).This medicine belongs to a group of medicines called azole antifungals.Clotrimazole reduces vaginal burning itching and discharge that may occur with this condition. This medication is an azole antifungal. It works by stopping the growth of yeast (fungus) that causes the infection.What is vaginal thrush?Candida albicans is a yeast fungus that can multiply rapidly and cause damage to the vagina when other micro-organisms aren't present in a normal balance.Some situations which can increase susceptibility to thrush are:#diabetes #obesity #illness #fatigue #hormonal fluctuations (pregnancy menstrual cycle oral contraceptive pill HRT) #prolonged use of antibiotics or steroids Thrush may cause the following symptoms:vaginal itching vaginal soreness a white odourless discharge from the vagina (like cottage cheese) pain during intercourse The symptoms below are not usually signs of thrush:abnormal or irregular vaginal bleeding blood stained discharge vulva or vaginal sores ulcers or blisters lower abdominal pain pain when passing urine fever or chills foul smelling and/or unusual coloured discharge Buy Clomazol Femcare and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Clomazol Femcare: Product Type: Prescription Drugs 4 Clomazol ( Femcare Gyne-Lotrimin Mycelex Generic Clotrimazole ) Clomazol (Femcare Gyne-Lotrimin Mycelex Generic Clotrimazole) Femcare Gyne-Lotrimin Mycelex Generic Clotrimazole Vag Cream+6 Appl. Topical Cream 35gm 20gm 60gm(3 x 20gm) Femcare Gyne-Lotrimin Mycelex Generic Clotrimazole Clomazol
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
